INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
SEC FORM 4/Option exerciseVerified dataRule 10b5-1 plan

Feuardent Moreira Andreas reported LAES

Chief Innovation Officer · SEALSQ Corp · SEALSQ Corp — Employee Stock Option Plan (right to buy)

Side
M
Value
—
Shares
10.0K
Price
—
Executed
Apr 7, 2026
Disclosed
Apr 8, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Apr 7 executedApr 8, 2026 disclosed

LAES · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
0/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · LAES

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    7
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M$200
    20.0K sh
    		Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    		+1dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M—
    15.0K sh
    		Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    		+1dSEC FORM 4

    Evidence

    7
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M—
    20.0K sh
    		Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    		+1dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Grant or award · 10b5-1 plan
    		A—
    50.0K sh
    		Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    		+1dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M$150
    15.0K sh
    		Nov 2, 2026Nov 3, 2026
    traded Nov 2, 2026
    		+1dSEC FORM 4

    Evidence

    13
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Open-market sale · 10b5-1 plan
    		SELL$48K
    35.0K sh
    		Nov 3, 2026Nov 3, 2026
    traded Nov 3, 2026
    		+0dSEC FORM 4

    Evidence

    16
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Open-market sale · 10b5-1 plan
    		SELL$86K
    35.0K sh
    		Oct 6, 2026Oct 7, 2026
    traded Oct 6, 2026
    		+1dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M—
    35.0K sh
    		Oct 5, 2026Oct 7, 2026
    traded Oct 5, 2026
    		+2dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Grant or award · 10b5-1 plan
    		A—
    50.0K sh
    		Oct 5, 2026Oct 7, 2026
    traded Oct 5, 2026
    		+2dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M$350
    35.0K sh
    		Oct 5, 2026Oct 7, 2026
    traded Oct 5, 2026
    		+2dSEC FORM 4

    Evidence

    19
    FA
    Fergusson David AlexanderDirector
    LAESSEALSQ Corp
    Grant or award
    		A—
    14.1K sh
    		Sep 25, 2026Oct 6, 2026
    traded Sep 25, 2026
    		+11dSEC FORM 4

    Evidence

    19
    PA
    Pellaton Eric AdrienDirector
    LAESSEALSQ Corp
    Grant or award
    		A—
    14.1K sh
    		Sep 25, 2026Oct 6, 2026
    traded Sep 25, 2026
    		+11dSEC FORM 4

    Evidence

    9
    WP
    Ward PeterDirector
    LAESSEALSQ Corp
    Grant or award
    		A—
    3,582 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    9
    WP
    Ward PeterDirector
    LAESSEALSQ Corp
    Grant or award
    		A—
    4,686 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    19
    PA
    Pellaton Eric AdrienDirector
    LAESSEALSQ Corp
    Grant or award
    		A—
    10.7K sh
    		Sep 25, 2026Oct 6, 2026
    traded Sep 25, 2026
    		+11dSEC FORM 4

    Evidence

    19
    FA
    Fergusson David AlexanderDirector
    LAESSEALSQ Corp
    Grant or award
    		A—
    3,424 sh
    		Sep 25, 2026Oct 6, 2026
    traded Sep 25, 2026
    		+11dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M$150
    15.0K sh
    		Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    		+2dSEC FORM 4

    Evidence

    0
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Option exercise · 10b5-1 plan
    		M—
    15.0K sh
    		Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    		+2dSEC FORM 4

    Evidence

    13
    EP
    Enguent Jean-PierreVice President, R&DSS
    LAESSEALSQ Corp
    Open-market sale · 10b5-1 plan
    		SELL$36K
    15.0K sh
    		Sep 3, 2026Sep 3, 2026
    traded Sep 3, 2026
    		+0dSEC FORM 4

    Evidence

    9
    WP
    Ward PeterDirector
    LAESSEALSQ Corp
    Option exercise
    		M—
    13.6K sh
    		Jun 16, 2026Jun 18, 2026
    traded Jun 16, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002115483-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Apr 7, 2026
    Published
    Apr 8, 2026
    Ingested by INSIDER
    Nov 5, 04:06 UTC
    Last re-read
    Nov 5, 04:07 UTC

    Extracted facts

    Filer
    Feuardent Moreira Andreas
    Role
    Chief Innovation Officer
    Transaction
    Option exerciseAs filed: “M”
    Asset
    SEALSQ Corp — Employee Stock Option Plan (right to buy)
    Ticker
    LAES
    Shares
    10.0K
    Price per share
    $0
    Execution date (reported)
    Apr 7, 2026
    Owned after transaction
    0 shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    1

    What this establishes

    Feuardent Moreira Andreas filed this Form 4 reporting a option exercise of LAES on Apr 7, 2026. It became public on Apr 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Innovation Officer
    Feuardent Moreira Andreascik:0002115483
    Issuer
    SEALSQ Corpcik:0001951222

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.